EMEA-000576-PIP03-12-M02

Key facts

Invented name
Xeljanz
Active substance
Tofacitinib
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0071/2019
PIP number
EMEA-000576-PIP03-12-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
Oral use
Contact for public enquiries
Pfizer Limited 
United Kingdom 
E-mail: pip_enquiries@pfizer.com 
Tel. +44 (0)1304 646607
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating